Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study

American Journal of Kidney Diseases

Volumn 55, Issue 3, 2010, Pages 507-518

  Lai, Ming Nan ^a   Lai, Jung Nien ^b   Chen, Pau Chung ^a   Hsieh, Shu Ching ^c   Hu, Fu Chang ^d   Wang, Jung Der ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c Center for Drug Evaluation   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aristolochic acid; Chinese herb nephropathy; end stage renal disease; Fangchi; Mu Tong

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG; FANGCHI; MU TONG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INDICATION; FEMALE; GROUPS BY AGE; HERBAL MEDICINE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEURALGIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ARISTOLOCHIC ACIDS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN;

EID: 77049088904     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.10.055     Document Type: Article

References (36)

1. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the United States Renal Data System 2004 Annual Data Report: international comparisons. Am J Kidney Dis 45 1 suppl 1 (2005) S217-S224
2. Kuo H.W., Tsai S.S., Tiao M.M., and Yang C.Y. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 49 1 (2007) 46-55
3. Yang W.C., and Hwang S.J. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 23 12 (2008) 3977-3982
4. Hsu C.C., Hwang S.J., Wen C.P., et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 48 5 (2006) 727-738
5. Yang C.S., Lin C.H., Chang S.H., and Hsu H.C. Rapidly progressive interstitial renal fibrosis associated Chinese herbal drug. Am J Kidney Dis 35 2 (2000) 313-318
6. Chang C.H., Wang Y.M., Yang A.H., and Chiang S.S. Rapidly progressive interstitial fibrosis associated with Chinese herbal medications. Am J Nephrol 21 6 (2001) 441-448
7. Yang H.Y., Lin J.L., Chen K.H., et al. Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin. J Nephrol 19 1 (2006) 111-114
8. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 8842 (1993) 387-391
9. Wen C.P., Cheng T.Y.D., Tsai M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet 371 9631 (2008) 2173-2182
10. Hsieh S.C., Lai J.N., Lee C.F., Hu F.C., Tseng W.L., and Wang J.D. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Safety 17 6 (2008) 609-619
11. Committee on Chinese Medicine and Pharmacy, the Department of Health. Regulation of drugs [in Chinese]. http://www.ccmp.gov.tw/public/public.asp?selno=816&relno=816&level=C Accessed January 10, 2008
12. Government Information Office. Taiwan yearbook 2004, public health: health insurance. http://www.gio.gov.tw/taiwan-website/5-gp/yearbook/2004/P243.htm Accessed December 25, 2009
13. Lai M.N., Lai J.N., Chen P.C., et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology 14 2 (2009) 227-234
14. National Health Research Institutes. National Health Insurance Research database. http://www.nhri.org.tw/nhird/date_01.html#_edn1 Accessed January 3, 2009
15. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
16. Committee on Chinese Medicine and Pharmacy, the Department of Health. Unified formulas. http://www.ccmp.gov.tw/en/information/formula.asp?relno=52&level=C Accessed January 10, 2008
17. Hsu Y.H., Tseng H.H., and Wen K.C. Determination of aristolochic acid in Fangchi radix [in Chinese]. Annual Report of National Laboratory of Food and Drug (1997), Bureau of Food and Drug Analysis, Taiwan ROC 136-142 15
18. Tung C.F., Ho Y.L., Tsai H.Y., and Chong Y.S. Studies on the commonly misused and adulterated Chinese crude drug species in Taiwan [in Chinese]. Chin Med Coll J 8 1 (1999) 35-46
19. Deng J.S. Quality Evaluation of Fang-Ji and Analysis of Marker Constituents. [dissertation] (2002), Institute of Chinese Pharmaceutical Sciences, China Medical University, Taiwan 75-77
20. Chuang M.S., Hsu Y.H., Chang H.C., Lin J.H., and Liao C.H. Studies on adulteration and misusage of marketed Akebiae caulisn [in Chinese]. Annual Report of National Laboratory of Food and Drug (2002), Bureau of Food and Drug Analysis, Taiwan ROC 104-119 20
21. Ahmad O., Boschi-Pinto C., Lopez A., Murray C., Lozano R., and Inoue M. Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series no. 31 (2000), World Health Organization, Geneva, Switzerland
22. Taiwan Bureau of Heath Promotion, Department of Health. C2003: Adult and Elderly Health Division [in Chinese]. http://www.bhp.doh.gov.tw/health91/study-2.htm Accessed February 10, 2008
23. Feest T.G., Mistry C.D., Grimes D.S., and Mallick N.P. Incidence of advanced chronic renal failure and the need for end-stage renal replacement treatment. BMJ 301 6757 (1990) 897-903
24. Maisonneuve P. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 35 1 (2000) 157-165
25. Dubach U.C., Rosner B., and Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin: renal morbidity and mortality (1968-1979). N Engl J Med 308 7 (1983) 357-362
26. Sandler D.P., Smith J.C., Weinberg C.R., et al. Analgesic use and chronic renal disease. N Engl J Med 320 19 (1989) 1238-1243
27. Perneger T.V., Whelton P.K., and Klag M.J. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331 25 (1994) 1675-1679
28. Feinstein A.R., Heinemann L.A., Curhan G.C., et al. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int 58 6 (2000) 2259-2264
29. Martena M.J., van der Wielen J.C.A., van der Laak L.F.J., Konings E.J.M., de Groot H.N., and Rietjens I.M.C.M. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal Bional Chem 389 1 (2007) 263-275
30. Vanhaelen M., Vanhaelen-Fastre R., But P., and Vanherweghem J.L. Identification of aristolochic acid in Chinese herbs [letter]. Lancet 343 8890 (1994) 174
31. Martinez M.M., Nortier J., Vereerstraeten P., and Vanherweghem J.L. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 17 3 (2002) 408-412
32. Ohno T., Mikami E., Matsumoto H., and Kawaguchi N. Identification tests of aristolochic acid in crude drugs by reversed-phase TLC/scanning densitometry. J Health Sci 52 1 (2006) 78-81
33. Jong T.T., Lee M.R., Hsiao S.S., et al. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 33 4 (2003) 831-837
34. Hsu Y.H., Lo C.F., Chang H.C., and Lin J.H. Studies on adulteration and misusage of Asari radi in the market [in Chinese]. Annual Report of National Laboratory of Food and Drug (2003), Bureau of Food and Drug Analysis, Taiwan ROC 153-167 21
35. Chen X.Q., and Wang S.S. Cardiac arrhythmia induced by excessive xi xin (1 case) [abstract] [in Chinese]. Jiangsu J Tradit Chin Med 15 1 (1994) 10
36. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74 2 (2008) 158-169